Page last updated: 2024-11-04

2-phosphoglycerate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-phosphoglycerate (2PG) is an important intermediate in glycolysis, the metabolic pathway that breaks down glucose to produce energy. It is formed from the isomerization of 3-phosphoglycerate by the enzyme phosphoglycerate mutase. 2PG is then converted to phosphoenolpyruvate (PEP) by the enzyme enolase. PEP is a high-energy compound that is used to generate ATP in the subsequent step of glycolysis. 2PG plays a role in other metabolic pathways, such as gluconeogenesis, the synthesis of glucose from non-carbohydrate sources. 2PG is also a substrate for the enzyme phosphoglycerate kinase, which catalyzes the reversible phosphorylation of ADP to ATP. 2PG is also a key intermediate in the biosynthesis of several important biomolecules, including serine, glycine, and cysteine. 2PG is studied to understand its role in metabolism, energy production, and biosynthesis. Research into 2PG can lead to the development of new drugs or therapies for metabolic diseases, such as diabetes and obesity.'

2-phosphoglycerate: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-phosphoglyceric acid : A monophosphoglyceric acid having the phospho group at the 2-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID59
CHEBI ID24344
SCHEMBL ID77985
MeSH IDM0053126

Synonyms (33)

Synonym
2-phosphoglyceric acid
propanoic acid, 3-hydroxy-2-(phosphonooxy)
glyceric acid, 2-(dihydrogen phosphate) (8ci)
2-phospho-dl-glyceric acid
dl-2-phosphoglycerate
propanoic acid, 3-hydroxy-2-(phosphonooxy)- (9ci)
glycerate 2-phosphate
glyceric acid 2-phosphate
2-p-glycerate
2553-59-5
2-p-d-glycerate
D60B5ED3-6117-4D39-B1A5-E346FCBBC78C
3-hydroxy-2-phosphonooxypropanoic acid
2-phosphoglycerate
propanoic acid, 3-hydroxy-2-(phosphonooxy)-
l-2-phosphoglyceric acid disodium salt hydrate
SCHEMBL77985
CHEBI:24344
3-hydroxy-2-(phosphonooxy)propanoic acid
23295-92-3
2-p-glyceric acid
2-(dihydrogen phosphate)glyceric acid
3-hydroxy-2-phosphonooxypropanoate
2-(dihydrogen phosphate)glycerate
2-p-d-glyceric acid
l-glycerate2-phosphatedisodiumsalt,disodiuml-2-phosphoglycerate
Q209469
l-2-phosphoglyceric acid disodium salt h
DTXSID20948430
CS-0062328
HY-113167
PD041462
AKOS040758631
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
monophosphoglyceric acidA glyceric acid phosphate in which only one of the hydroxy groups has been phosphorylated.
tetronic acid derivativeAn aldonic acid derivative that is formally obtained from a tetronic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (11)

PathwayProteinsCompounds
D-Glucarate and D-Galactarate Degradation1022
Gluconeogenesis from L-Malic Acid2024
Aerobic glycolysis020
Warburg effect modulated by deubiquitinating enzymes and their substrates011
Metabolic Epileptic Disorders2589
Relationship between glutathione and NADPH036
Hexoses metabolism in proximal tubules016
Glycolysis010
Primary carbon metabolism2330
Glycolysis and Gluconeogenesis08
Metabolic reprogramming in colon cancer029
Glycolysis and gluconeogenesis017

Research

Studies (80)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (20.00)18.7374
1990's28 (35.00)18.2507
2000's15 (18.75)29.6817
2010's18 (22.50)24.3611
2020's3 (3.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.81 (24.57)
Research Supply Index4.42 (2.92)
Research Growth Index4.67 (4.65)
Search Engine Demand Index70.61 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.44%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other80 (97.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]